WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
90.40
+0.81 (0.90%)
At close: Dec 5, 2025
75.60%
Market Cap 269.53B
Revenue (ttm) 43.88B
Net Income (ttm) 14.99B
Shares Out 2.96B
EPS (ttm) 4.65
PE Ratio 17.89
Forward PE 14.74
Dividend 0.70 (0.78%)
Ex-Dividend Date Sep 26, 2025
Volume 38,458,130
Average Volume 34,724,385
Open 90.25
Previous Close 89.59
Day's Range 89.52 - 91.48
52-Week Range 48.48 - 115.79
Beta 0.82
RSI 42.72
Earnings Date Mar 15, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.